A polymorphism in New Zealand inbred mouse strains that inactivates phosphatidylcholine transfer protein
暂无分享,去创建一个
H. Pan | E. Leiter | Diana S. Agate | S. Roderick | Michele K. Wu | David E. Cohen | Benjamin L. King
[1] K. Wirtz. Phospholipid transfer proteins in perspective , 2006, FEBS letters.
[2] D. Vance,et al. Adverse hepatic and cardiac responses to rosiglitazone in a new mouse model of type 2 diabetes: relation to dysregulated phosphatidylcholine metabolism. , 2006, Vascular pharmacology.
[3] D. Cohen,et al. Phosphatidylcholine transfer protein regulates size and hepatic uptake of high-density lipoproteins. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[4] D. Vance,et al. Pharmacogenetic analysis of rosiglitazone-induced hepatosteatosis in new mouse models of type 2 diabetes. , 2005, Diabetes.
[5] I. Tabas,et al. Decreased lipid efflux and increased susceptibility to cholesterol-induced apoptosis in macrophages lacking phosphatidylcholine transfer protein. , 2005, The Biochemical journal.
[6] D. Cohen,et al. Altered hepatic cholesterol metabolism compensates for disruption of phosphatidylcholine transfer protein in mice. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[7] P. Novikoff,et al. Impaired response of biliary lipid secretion to a lithogenic diet in phosphatidylcholine transfer protein-deficient mices⃞s⃞ The online version of this article (available at http://www.jlr.org) contains an additional table. Published, JLR Papers in Press, December 1, 2004. DOI 10.1194/jlr.M400387-JL , 2005, Journal of Lipid Research.
[8] J. Breslow,et al. StAR-related Lipid Transfer (START) Proteins: Mediators of Intracellular Lipid Metabolism* , 2003, Journal of Biological Chemistry.
[9] J. Bruce German,et al. Lipid metabolome-wide effects of the PPARγ agonist rosiglitazones⃞s The online version of this article (available at http://www.jlr.org) contains an additional 4 tables. Published, JLR Papers in Press, August 16, 2002. DOI 10.1194/jlr.M200169-JLR200 , 2002, Journal of Lipid Research.
[10] E. Leiter,et al. Deconstructing and reconstructing obesity-induced diabetes (diabesity) in mice. , 2002, Diabetes.
[11] D. Cohen,et al. Phosphatidylcholine Transfer Protein Promotes Apolipoprotein A-I-mediated Lipid Efflux in Chinese Hamster Ovary Cells* , 2002, The Journal of Biological Chemistry.
[12] J Bruce German,et al. Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone. , 2002, Journal of lipid research.
[13] M. Vetting,et al. Structure of human phosphatidylcholine transfer protein in complex with its ligand , 2002, Nature Structural Biology.
[14] Y. Sugiyama,et al. Etiologic significance of defects in cholesterol, phospholipid, and bile acid metabolism in the liver of patients with intrahepatic calculi , 2001, Hepatology.
[15] D. Cohen,et al. High-level expression and mutagenesis of recombinant human phosphatidylcholine transfer protein using a synthetic gene: evidence for a C-terminal membrane binding domain. , 2000, Biochemistry.
[16] J. Hurley,et al. Structure and lipid transport mechanism of a StAR-related domain , 2000, Nature Structural Biology.
[17] D. Beier,et al. Cloning, tissue-specific expression, gene structure and chromosomal localization of human phosphatidylcholine transfer protein. , 1999, Biochimica et biophysica acta.
[18] K. Wirtz,et al. Mice without phosphatidylcholine transfer protein have no defects in the secretion of phosphatidylcholine into bile or into lung airspaces. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[19] D. Cohen,et al. Cloning and gene structure of rat phosphatidylcholine transfer protein, Pctp. , 1999, Gene.
[20] C. Ponting,et al. START: a lipid-binding domain in StAR, HD-ZIP and signalling proteins. , 1999, Trends in biochemical sciences.
[21] D. Cohen,et al. Baculovirus-mediated expression of recombinant rat phosphatidylcholine transfer protein. , 1998, Journal of lipid research.
[22] E. Leiter,et al. NIDDM Genes in Mice: Deleterious Synergism by Both Parental Genomes Contributes to Diabetogenic Thresholds , 1998, Diabetes.
[23] Geoffrey J. Barton,et al. JPred : a consensus secondary structure prediction server , 1999 .
[24] K. Wirtz,et al. cDNA cloning and tissue-specific expression of the phosphatidylcholine transfer protein gene. , 1996, The Biochemical journal.
[25] J. Thompson,et al. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.
[26] M. Festing. Origins and characteristics of inbred strains of mice, 14th listing , 1992 .
[27] W. Dowhan,et al. Phospholipid-transfer proteins. , 1991, Current opinion in cell biology.
[28] J. Zou,et al. Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.
[29] K. Wirtz. Phospholipid transfer proteins. , 1991, Annual review of biochemistry.
[30] M. Lyon,et al. Genetic variants and strains of the laboratory mouse , 1989 .
[31] E. Triphosphat,et al. FEBS Letters , 1987, FEBS Letters.
[32] M. Deol. Genetic Variants and Strains of the Laboratory Mouse , 1983 .
[33] D. B. Zilversmit,et al. Protein-catalyzed exchange of phosphatidylcholine between sonicated liposomes and multilamellar vesicles. , 1977, Biochemistry.
[34] C. Goodall,et al. Origin of inbred NZ mouse strains. , 1970, Cancer research.